Swindon-based commercial lawyers Clark Holt have acted as legal advisers to the shareholders of Oxford-based Absolute Antibody, and its sister company Kerafast, on their sale to American company LSBio.

It is a further example of Clark’s Holt’s transactional work in the life science sector. The Clark Holt team was led by corporate partner Philip Humphreys, working alongside Tim Bernard at Pivotal Scientific in managing the M&A process. Clifford Chance, Polsinelli and KPMG acted for LSBio.
Absolute Antibody specialises in recombinant antibody technology, offering antibody sequencing, engineering and recombinant production as custom services.